Who is KHONA SCIENTIFIC
Khona Scientific Inc. (KSI) is a synthetic biology company using a patented biosynthesis platform (BiDSTM) to produce rare cannabinoids. These cannabinoids are made in very small quantiti...
Read More
![map](/x-assets/maps1.0-950f22e3512fa69a51fdf6612dcb593a74c2f8790b6e4ec5601cebb82b592ab9.png)
-
Headquarters: Denver, Colorado, United States
-
Date Founded: 2019
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
-
CEO: Paul Orlady
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from KHONA SCIENTIFIC
Khona Scientific Org Chart and Mapping
Similar Companies to Khona Scientific
Bio-Well
-
1-10
-
$ Under 1 Million
The BioCollective
-
1-10
-
$ 5 Million to 10 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Khona Scientific
Answer: Khona Scientific's headquarters are located at Denver, Colorado, United States
Answer: Khona Scientific's official website is https://khonascientific.com
Answer: Khona Scientific's revenue is Under $1 Million
Answer: Khona Scientific's SIC: 2836
Answer: Khona Scientific's NAICS: 541714
Answer: Khona Scientific has 1-10 employees
Answer: Khona Scientific is in Biotechnology
Answer: Khona Scientific top competitors include: Bio-Well , The BioCollective
Answer: Khona Scientific contact info: Phone number: Website: https://khonascientific.com
Answer: Khona Scientific Inc. (KSI) is a synthetic biology company using a patented biosynthesis platform (BiDSTM) to produce rare cannabinoids. These cannabinoids are made in very small quantities within plants, and thus cannot be produced cost-effectively using agricultural methods. KSI is positioning itself as an industrial-scale B2B supplier of cGMP-grade cannabinoids for companies making consumer products across multiple verticals including: - Health & Beauty/Cosmetics - Veterinary - Food & Beverage - Nutraceuticals Competing technologies address the problem of cannabinoid biosynthesis using a "step-wise" approach. In contrast, the BiDSTM platform organizes the 20+ biological steps necessary for cannabinoid production into an "assembly line". This "systems-level" approach to biosynthesis mimics nature, allowing targeted and efficient production of key cannabinoids. BiDSTM cannabinoid production - key takeaways: Plant-free (uses yeast and sugar) 90% conversion efficiency @ 24 hours Industrially viable yields (even before optimization) 100% THC-free Production in a controlled environment No contaminants (mold, pesticides, heavy metals) Offers a transparent & traceable supply chain Initial production: CBG, CBGa, CBC, CBCa, CBD, CBDa Future production: CBGV, CBGVa, CBCV, CBCVa, CBDV, CBDVa, THCV, THCVa, CBN, CBNa, CBV, CBT, CBTV, and CBLV Commercial production begins Q3 2023.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month